VYOME HOLDINGS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
VYOME HOLDINGS, INC. (HIND) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.28 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-12
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 3.28M shares, a 78.55% decline year-over-year.
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 15.30M shares.
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2021-03-31 was 2.21M shares, a 41.33% decline year-over-year.
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2020-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 4.25M shares, a 126407.60% increase from fiscal 2024.
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 3.36K shares.
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2020 was 4.47M shares, a 17.98% increase from fiscal 2019.
- VYOME HOLDINGS, INC. antidilutive securities excluded from computation of earnings per share, amount for fiscal 2019 was 3.79M shares, a 9783.04% increase from fiscal 2018.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 3.28M shares 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | 3.28M shares 10-Q · filed 2026-05-12 | ||||||
| 2025-12-31 | 4.25M shares 10-K · filed 2026-03-18 | ||||||
| 2025-09-30 | 4.48M shares 10-Q · filed 2025-11-14 | ||||||
| 2025-06-30 | 3.35K shares 10-Q · filed 2026-08-12 | ||||||
| 2025-03-31 | 15.30M shares 10-Q · filed 2026-05-12 | ||||||
| 2024-12-31 | 3.36K shares 10-K · filed 2026-03-18 | ||||||
| 2024-09-30 | 3.37K shares 10-Q · filed 2025-11-14 | ||||||
| 2021-03-31 | 2.21M shares 10-Q · filed 2021-05-12 | ||||||
| 2020-12-31 | 4.47M shares 10-K · filed 2021-03-12 | ||||||
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-06 | 0.00 shares 10-Q · filed 2020-11-06 | |||||
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-07-30 | 0.00 shares 10-Q · filed 2020-07-30 | |||||
| 2020-03-31 | 3.77M shares 10-Q · filed 2021-05-12 | 0.00 shares 10-Q · filed 2020-06-19 | |||||
| 2019-12-31 | 3.79M shares 10-K · filed 2021-03-12 | 8.90K shares 10-K · filed 2020-02-27 | |||||
| 2019-09-30 | 8.00 shares 10-Q · filed 2020-11-06 | 5.33K shares 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | 0.00 shares 10-Q · filed 2020-07-30 | 112.89K shares 10-Q · filed 2020-07-30 | |||||
| 2019-03-31 | 182.18K shares 10-Q · filed 2020-06-19 | ||||||
| 2018-12-31 | 38.35K shares 10-K · filed 2020-02-27 | 383.51K shares 10-K · filed 2019-02-22 | |||||
| 2018-09-30 | 25.97K shares 10-Q · filed 2019-11-08 | 259.68K shares 10-Q · filed 2018-11-02 | 42.47K shares 10-Q · filed 2019-11-08 | 424.73K shares 10-Q · filed 2018-11-02 | |||
| 2018-06-30 | 383.26K shares 10-Q · filed 2019-07-24 | 492.35K shares 10-Q · filed 2019-07-24 | |||||
| 2018-03-31 | 596.21K shares 10-Q · filed 2019-05-10 | 1.10M shares 10-Q · filed 2018-05-10 | |||||
| 2017-12-31 | 886.53K shares 10-K · filed 2019-02-22 | 990.23K shares 10-K · filed 2018-03-05 | |||||
| 2017-09-30 | 873.28K shares 10-Q · filed 2018-11-02 | 886.24K shares 10-Q · filed 2017-11-03 | 904.75K shares 10-Q · filed 2018-11-02 | 909.07K shares 10-Q · filed 2017-11-03 | |||
| 2017-06-30 | 924.96K shares 10-Q · filed 2018-08-02 | 920.20K shares 10-Q · filed 2018-08-02 | |||||
| 2017-03-31 | 914.58K shares 10-Q · filed 2018-05-10 | ||||||
| 2016-12-31 | 830.14K shares 10-K · filed 2018-03-05 | ||||||
| 2016-09-30 | 10.52M shares 10-Q · filed 2017-11-03 | 9.75M shares 10-Q · filed 2017-11-03 | |||||
| 2016-06-30 | 9.84M shares 10-Q · filed 2017-08-02 | 9.39M shares 10-Q · filed 2017-08-02 | |||||
| 2016-03-31 | 8.45M shares 10-Q · filed 2017-05-10 | ||||||
| 2015-12-31 | 8.44M shares 10-K · filed 2018-03-05 | ||||||
| 2015-09-30 | 8.44M shares 10-Q · filed 2016-11-10 | 8.44M shares 10-Q · filed 2016-11-10 | |||||
| 2014-12-31 | 6.71M shares 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |